What methods can the Food and Drug Administration (FDA) and other regulatory bodies use to evaluate the efficacy of novel anti‐infective technologies? G161 Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on LinkedIn (Opens in new window)MoreClick to print (Opens in new window)Click to share on Reddit (Opens in new window)Click to share on Pinterest (Opens in new window)Click to share on Pocket (Opens in new window)Click to share on Telegram (Opens in new window)Click to share on WhatsApp (Opens in new window)Click to email a link to a friend (Opens in new window)Like this:Like Loading...